Lenhard Miriam S, Bauerfeind Ingo, Untch Michael
Department of Obstetrics and Gynecology, Campus Grosshadern, Ludwig-Maximilians-University of Munich, Marchioninistrasse 15, 80337 Munich, Germany.
Crit Rev Oncol Hematol. 2008 Sep;67(3):196-203. doi: 10.1016/j.critrevonc.2008.02.007. Epub 2008 Apr 3.
Breast cancer is the second most frequently occurring malignancy during pregnancy. As evidence-based data on diagnostics and treatment is lacking, current recommendations mostly derive from nonrandomized experiences. We reviewed the current literature with focus on chemotherapy during pregnancy and lactation.
The diagnosis of pregnancy associated breast cancer implies the challenge to balance between a life-saving therapy for the mother's breast cancer and a potentially life-threatening therapy for the fetus. With few limitations, surgery and chemotherapy can be performed during pregnancy, preferably in the second and third trimester, whereas radiotherapy and endocrine or antibody treatment should be postponed until after delivery.
Breast cancer during pregnancy and lactation remains a therapeutic and ethical multidisciplinary challenge. Close cooperation between all disciplines is inevitable to find an optimal treatment strategy for the mother and her unborn child.
乳腺癌是孕期第二常见的恶性肿瘤。由于缺乏关于诊断和治疗的循证数据,目前的建议大多源自非随机经验。我们回顾了当前文献,重点关注孕期和哺乳期的化疗。
妊娠相关乳腺癌的诊断意味着要在挽救母亲乳腺癌生命的治疗与对胎儿可能有生命威胁的治疗之间取得平衡。手术和化疗在孕期可进行,限制较少,最好在孕中期和孕晚期进行,而放疗、内分泌或抗体治疗应推迟至分娩后。
孕期和哺乳期的乳腺癌仍然是一个治疗和伦理方面的多学科挑战。所有学科之间密切合作对于为母亲及其未出生的孩子找到最佳治疗策略是必不可少的。